NOVARTIS AG (NVSEF)
Clinical trial NCT06824103 updates: 1. completion date: 2032-01-11 → 2031-05-23 2. enrollment: not set → 50 participants
Clinical trial NCT06824103 updates: 1. completion date: 2032-01-11 → 2031-05-23 2. enrollment: not set → 50 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical